Register or Sign in to Save this opportunity, or Send an Inquiry.
Novel Compounds for Anxiety, Epilepsy and Neuropathic Pain
Milwaukee Regional Technology Transfer Group United States flag United States
Abstract ID:
The inventors from the laboratory of Dr. James Cook have synthesized novel imidazobenzodiazepine (IMBDZ) compounds that act as GABAergic receptor ligands that are ?3, ?2, or ?2/?3 subtype specific.
Send an Inquiry
RE:
Participants
You
Technology

The inventors from the laboratory of Dr. James Cook have synthesized novel imidazobenzodiazepine (IMBDZ) compounds that act as GABAergic receptor ligands that are α3, α2, or α2/α3 subtype specific.

GO PREMIUM TO GET PATENT INFORMATION
Type of Business Relationship Sought

This technology is part of an active and ongoing research program and is seeking partners for development of the final product. It is available for developmental research support/licensing under either exclusive or non-exclusive terms.

FEATURED
Last Updated Oct 2014
Technology Type
Phase of Development EARLY STAGE
UNIVERSITY

Researchers

Opportunity Contact